We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $102M
1-Year Est. Return 59.84%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+59.84%
3 Year Est. Return
+135.67%
5 Year Est. Return
+165.06%
10 Year Est. Return
AUM
$147M
AUM Growth
+$45.8M
Cap. Flow
+$35.4M
Cap. Flow %
24.09%
Top 10 Hldgs %
15.71%
Holding
140
New
29
Increased
66
Reduced
32
Closed
13

Sector Composition

1 Technology 46.13%
2 Healthcare 13.67%
3 Real Estate 11.21%
4 Consumer Discretionary 6.6%
5 Industrials 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWST icon
101
Twist Bioscience
TWST
$5.84B
$728K 0.5%
+5,460
New +$635K
XYL icon
102
Xylem
XYL
$29.2B
$711K 0.48%
5,923
-581
-9% -$66.3K
PACB icon
103
Pacific Biosciences
PACB
$447M
$709K 0.48%
+20,279
New +$590K
VEON icon
104
VEON
VEON
$3.57B
$696K 0.47%
15,208
+10,569
+228% +$466K
TBIO
105
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$677K 0.46%
+24,575
New +$483K
QS icon
106
QuantumScape Corp
QS
$3.6B
$644K 0.44%
+22,022
New +$712K
WMS icon
107
Advanced Drainage Systems
WMS
$11.3B
$631K 0.43%
+5,417
New +$601K
ARCT icon
108
Arcturus Therapeutics
ARCT
$172M
$613K 0.42%
+18,122
New +$613K
HAIN icon
109
Hain Celestial
HAIN
$50.6M
$603K 0.41%
15,024
+7,574
+102% +$313K
ORA icon
110
Ormat Technologies
ORA
$6.43B
$597K 0.41%
8,582
+3,580
+72% +$255K
PSNL icon
111
Personalis
PSNL
$1.61B
$595K 0.41%
+23,537
New +$539K
INO icon
112
Inovio Pharmaceuticals
INO
$92.1M
$580K 0.39%
+5,214
New +$501K
PRMW
113
DELISTED
Primo Water Corporation
PRMW
$578K 0.39%
+34,558
New +$584K
SGEN
114
DELISTED
Seagen Inc. Common Stock
SGEN
$565K 0.38%
3,576
+505
+16% +$75K
EXAS
115
DELISTED
Exact Sciences
EXAS
$541K 0.37%
4,356
+1,659
+62% +$198K
ARRY icon
116
Array Technologies
ARRY
$940M
$522K 0.36%
+33,475
New +$706K
WFCF icon
117
Where Food Comes From
WFCF
$63.4M
$510K 0.35%
+32,952
New +$488K
PHG icon
118
Philips
PHG
$26.2B
$503K 0.34%
12,262
+3,680
+43% +$170K
NSTG
119
DELISTED
NanoString Technologies, Inc.
NSTG
$496K 0.34%
+7,648
New +$486K
VRTX icon
120
Vertex Pharmaceuticals
VRTX
$123B
$484K 0.33%
2,398
+479
+25% +$100K
PRLB icon
121
Protolabs
PRLB
$1.85B
$477K 0.32%
+5,196
New +$512K
CVAC
122
DELISTED
CureVac
CVAC
$334K 0.23%
+4,545
New +$454K
BLUE
123
DELISTED
bluebird bio
BLUE
$292K 0.2%
706
+137
+24% +$54.3K
ATHX
124
DELISTED
Athersys, Inc. Common Stock
ATHX
$256K 0.17%
+7,112
New +$293K
POWI icon
125
Power Integrations
POWI
$3.93B
$236K 0.16%
2,880
-3,446
-54% -$278K

Similar funds

Green Alpha Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Green Alpha Advisors held 140 positions worth $147M, up 45% from $101M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Green Alpha Advisors deployed $35.4M of net new capital in Q2 2021, opening 29 new positions and adding to 66 existing holdings. Its largest new stake was ASML: 2,173 shares worth $1.5M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 58% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Tesla, an estimated $1.95M trimmed.

  • Green Alpha Advisors's largest Q2 2021 buy was ASML: 2,173 shares worth $1.5M.
  • Green Alpha Advisors added most to Hudson Pacific Properties in Q2 2021, an estimated $1.72M increase.
  • Green Alpha Advisors's biggest Q2 2021 reduction was Tesla, cutting an estimated $1.95M.
  • Green Alpha Advisors fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $1.4M.
  • Green Alpha Advisors's ten largest holdings make up 16% of its $147M portfolio in Q2 2021.
  • Green Alpha Advisors opened 29 new positions and closed 13 in Q2 2021.
  • Green Alpha Advisors's portfolio value rose 45% quarter-over-quarter to $147M.

Based on Green Alpha Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.